Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1996-05-08
1999-08-03
McKane, Joseph
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540578, C07D22318
Patent
active
059325690
DESCRIPTION:
BRIEF SUMMARY
The present invention is concerned with triazolobenzazepine derivatives having antiallergic activity.
In EP-A-0,339,978 there are described (benzo- or pyrido)cyclohepta heterocyclics which are useful as PAF antagonists, antihistaminics and/or anti-inflammatory agents.
In WO 92/06981 there are described substituted imidazobenzazepines and imidazopyridoazepines having antiallergic and anti-inflammatory activity.
In J. Med. Chem., 26(1983), 974-980 there are described some derivatives having neuroleptic properties.
In DE-27,35,158 there are described triazolobenzazepine derivatives having analgesic activity.
The compounds of the present invention differ structurally from the cited art-known compounds by the fact that the central 7-membered ring invariably contains a nitrogen atom of a fused triazole ring, and by their favorable antiallergic activity.
The present invention is concerned with novel triazolobenzazepines of formula ##STR2## the pharmaceutically acceptable addition salts and stereochemically isomeric forms thereof, wherein
each of the dotted lines independently represents an optional bond;
R.sup.1 represents hydrogen, halo, C.sub.1-4 alkyl, hydroxy or C.sub.1-4 alkyloxy;
R.sup.2 represents hydrogen, halo, C.sub.1-4 alkyl, hydroxy or C.sub.1-4 alkyloxy;
R.sup.3 represents hydrogen, C.sub.1-4 alkyl or halo;
--B.dbd.D-- is a bivalent radical of formula ##STR3##
R.sup.4 represents hydrogen, C.sub.1-4 alkyl, ethenyl substituted with hydroxycarbonyl or C.sub.1-4 alkyloxycarbonyl, C.sub.1-4 alkyl substituted with hydroxycarbonyl or C.sub.1-4 alkyloxycarbonyl, hydroxyC.sub.1-4 alkyl, formyl or hydroxycarbonyl;
R.sup.5 represents hydrogen, C.sub.1-4 alkyl, ethenyl substituted with hydroxycarbonyl or C.sub.1-4 alkyloxycarbonyl, C.sub.1-4 alkyl substituted with hydroxycarbonyl or C.sub.1-4 alkyloxycarbonyl, hydroxyC.sub.1-4 alkyl, formyl, hydroxycarbonyl, phenyl or pyridinyl;
L represents hydrogen; C.sub.1-6 alkyl; C.sub.1-6 alkyl substituted with one substituent selected from the group consisting of hydroxy, C.sub.1-4 alkyloxy, hydroxycarbonyl, C.sub.1-4 alkyloxycarbonyl, C.sub.1-4 alkyloxycarbonylC.sub.1-4 alkyloxy, hydroxycarbonyl-C.sub.1-4 alkyloxy, C.sub.1-4 alkylaminocarbonylamino, C.sub.1-4 alkylaminothiocarbonylamino, aryl and aryloxy; C.sub.1-6 alkyl substituted with both hydroxy and aryloxy; C.sub.3-6 alkenyl; C.sub.3-6 alkenyl substituted with aryl; hydroxy, C.sub.1-4 alkyl, C.sub.1-4 alkyloxy or aminocarbonyl; or,
L represents a radical of formula ##STR4##
Alk represents C.sub.1-4 alkanediyl;
Y represents O, S or NH;
Het.sup.1, Het.sup.2 and Het.sup.3 each represent furanyl, thienyl, oxazolyl, thiazolyl or imidazolyl each optionally substituted with one or two C.sub.1-4 alkyl substituents; pyrrolyl or pyrazolyl optionally substituted with formyl, hydroxyC.sub.1-4 alkyl, hydroxycarbonyl, C.sub.1-4 alkyloxycarbonyl or one or two C.sub.1-4 alkyl substituents; thiadiazolyl or oxadiazolyl optionally substituted with amino or C.sub.1-4 alkyl; pyridinyl, pyrimidinyl, pyrazinyl or pyridazinyl each optionally substituted with C.sub.1-4 alkyl, C.sub.1-4 alkyloxy, amino, hydroxy or halo; and Het.sup.3 may also represent 4,5-dihydro-5-oxo-1H-tetrazolyl substituted with C.sub.1-4 alkyl, 2-oxo-3-oxazolidinyl, 2,3-dihydro-2-oxo-1H-benzimidazol-1-yl or a radical of formula ##STR5## --A--Z-- represents --S--CH.dbd.CH--, --S--CH.sub.2 --CH.sub.2 --, --S--CH.sub.2 --CH.sub.2 --CH.sub.2 --, --CH.dbd.CH--CH.dbd.CH-- or --CH.sub.2 --CH.sub.2 --CH.sub.2 --CH.sub.2 --.
As used in the foregoing definitions halo defines fluoro, chloro, bromo and iodo; C.sub.1-4 alkyl defines straight and branched chain saturated hydrocarbon radicals having from 1 to 4 carbon atoms such as, for example, methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl and 1,1-dimethylethyl; C.sub.1-6 alkyl defines C.sub.1-4 alkyl radicals as defined hereinbefore and the higher homologs thereof having from 5 to 6 carbon atoms such as, for example, pentyl and hexyl; C.sub.3-6 alkenyl defines straight and branched chain hydrocarbon r
REFERENCES:
patent: 5468743 (1995-11-01), Janssens et al.
Janssens Frans Eduard
Lacrampe Jean Fernand Armand
Pilatte Isabelle Noelle Constance
Ciambrone Coletti Ellen
Janssen Pharmaceutica N.V.
McKane Joseph
LandOfFree
Triazolobenzazepine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Triazolobenzazepine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazolobenzazepine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-849640